← Back to guidelines
Cardiology1 paper

Pleomorphic adenoma

Last edited: 6 h ago

Overview

Pleomorphic adenoma is the most common benign neoplasm of the salivary glands, characterized by its biphasic pattern of epithelial and myoepithelial cells 1.

Diagnosis

  • Histopathological Examination: Essential for diagnosis, showing dual epithelial and myoepithelial cell populations 1.
  • Immunohistochemistry: Utilize S100 and smooth muscle actin (SMA) stains to confirm myoepithelial cell presence 1.
  • Intravascular Tumor Identification: Rarely, intravascular tumor infiltration by plasmacytoid myoepithelial cells may be observed; requires thorough serial section analysis 1.
  • Management

  • Surgical Excision: Wide local excision with clear margins is the standard treatment 1.
  • Further Analysis for Intravascular Components: In cases where intravascular tumor is identified, consider additional histopathological scrutiny to rule out malignancy 1.
  • Special Populations

  • No Specific Guidelines Provided: The abstract does not cover special populations such as pregnancy, pediatrics, elderly, or comorbidities 1.
  • Key Recommendations

  • Perform wide local excision with clear margins for pleomorphic adenomas to ensure complete removal 1 (Evidence: Strong).
  • Conduct thorough histopathological examination including serial sections and immunohistochemistry (S100, SMA) to identify intravascular tumor components 1 (Evidence: Moderate).
  • Monitor for intravascular tumor infiltration by plasmacytoid myoepithelial cells, though currently no specific adjunctive treatments are indicated beyond thorough surgical and pathological assessment 1 (Evidence: Weak).
  • References

    1 Coleman H, Altini M. Intravascular tumour in intra-oral pleomorphic adenomas: a diagnostic and therapeutic dilemma. Histopathology 1999. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Pricing·Privacy & Terms·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG